U.S. pharma giant copyright scrapped two experimental weight loss supplements last 12 months—a when-everyday pill, lotiglipron, on account of elevated liver enzymes and also a 2 times-each day tablet, danuglipron, as a consequence of potent Unwanted side effects—but CEO Albert Bourla has reported the company is determined to “Perform and win�